Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
What are the benefits of probiotics? Does any particular kind offer more benefits than the others?
An 85% remission rate was noted in a group of patients with acute myeloid leukemia who received the histone deacetylase inhibitor vorinostat in addition to cytarabine and idarubicin.
The IV antimicrobial tigecycline, indicated for the treatment of various infections, targets and destroys leukemia stem cells by cutting off the cell's energy production.
Should patients receive a test dose of bleomycin? If yes, should the test dose be administered with every dose or just the initial dose?
The regulatory protein FoxM1 is essential for the continued growth of medulloblastoma and is significantly and negatively correlated with survival, making it a useful prognostic marker.
A recently FDA-approved treatment and an experimental BRAF inhibitor offer hope to patients with metastatic melanoma.
Treatment-related pain is debilitating for patients. Many medications are not effective, but some techniques can alleviate patients' discomfort.
Prophylactic antibiotics, barrier isolation and air quality control measures can substantially reduce the risk of death in high-risk cancer patients after chemotherapy, a systematic review has shown
Sign Up for Free e-newsletters
- Risk prediction improved by new classification in chronic lymphocytic leukemia
- Treatment options for HER2-positive breast cancer
- Antimicrobial agent triclosan, used in soaps and detergents, may cause cancer
- The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
- Disparities in non-small cell lung cancer (NSCLC) treatment based on race, treatment center
- A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
- Early palliative care can cut hospital readmissions for cancer patients
- ONA Interview: Breaking the barriers to effective palliative care
- Fluorescent tattoos may improve self-esteem in patients receiving radiotherapy for breast cancer
- Cancer prehabilitation: One step toward improved outcomes
- Radiation exposure linked to aggressive thyroid cancers
- More patients opt for mastectomy despite limited, early-stage breast cancer
- Calcium channel blockers not found to increase risk of breast cancer
- Being overweight or obese may hide true nutritional status of patients with cancer
- Monitoring psychosocial function in radiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|